Slides presentate dal dr Vincenzo Patruno, SOC Pneumologia Riabilitativa, ASS4 Mediofriuli, nell'ambito del corso "Le malattie neuromuscolari", Udine, 16 dicembre 2013.
This document discusses obstructive sleep apnea (OSA). It defines OSA as recurrent episodes of apnea or hypopnea due to upper airway collapse during sleep. It reviews the prevalence of OSA in different populations and risk factors such as obesity, genetics, and upper airway abnormalities. The pathogenesis of OSA involves reduced airway size and increased collapsibility, as well as neural, muscle and fluid shift factors. Clinical symptoms, diagnostic tools like polysomnography, and treatment options including positive airway pressure and oral appliances are described in detail.
This document discusses ventilation strategies for a patient with acute respiratory distress syndrome (ARDS). It provides details of the patient's initial presentation and management, including mechanical ventilation settings. It describes the rationale for using low tidal volume ventilation to minimize ventilator-induced lung injury. The patient required aggressive management for sepsis and hypoxemia including recruitment maneuvers and increasing PEEP and mean airway pressures. Despite these efforts, the patient could not be weaned from high FiO2 and developed multi-organ failure and died. The document recommends using low tidal volumes, limiting end-inspiratory pressures, adequate PEEP, and considering recruitment maneuvers to optimize ventilation in ARDS.
The document summarizes the new sleep scoring guidelines from the American Academy of Sleep Medicine (AASM). Key changes include the addition of frontal EEG leads, closer EOG electrode placement, more chin EMG electrodes, and new definitions for sleep stages, arousals, respiratory events, and movements. The AASM guidelines were developed through an evidence-based process and aim to standardize sleep scoring based on advances in neurobiology and technology.
Sleep progresses through stages including REM sleep and NREM sleep. NREM sleep includes stages 1-4, with stages 3 and 4 being slow wave or deep sleep. A normal sleep cycle lasts 90-110 minutes and progresses from light to deep sleep and then to REM sleep before repeating. Lack of sleep or fragmented sleep can negatively impact health by reducing time in restorative sleep stages and increasing daytime sleepiness. Common sleep disorders include insomnia, sleep apnea, hypersomnias, and circadian rhythm disorders.
This document defines and describes sleep apnea, its types (obstructive, central, mixed), risk factors, symptoms, complications, diagnosis via polysomnography (PSG), and treatment options including weight loss, CPAP, oral devices, surgery, and management of obesity hypoventilation syndrome. Sleep apnea is characterized by pauses in breathing during sleep caused by airway collapse and is associated with daytime sleepiness and cardiovascular issues. PSG is the gold standard test to evaluate sleep architecture and breathing disturbances. Treatment focuses on maintaining an open airway through lifestyle changes and devices.
OSAS (OBSTRUCTIVE SLEEP APNEA SYNDROME) e disabilitàASMaD
Presentazione a cura del Professor Francescosaverio Caserta - XII° Congresso Nazionale FIMeG 2018 - The Silver Tsunami: l'anziano fra appropriatezza e farmaeconomia
This document discusses obstructive sleep apnea syndrome (OSAS). It begins by stating the prevalence of OSAS in India is 7.5% and is often undiagnosed. OSAS is characterized by cessation of airflow for more than 10 seconds during sleep that can be obstructive, central, or mixed in nature. Risk factors include obesity, older age, alcohol use, and certain medications. Polysomnography is the gold standard test used to diagnose OSAS and evaluate severity based on apnea hypopnea index. Untreated OSAS can lead to increased risks of hypertension, heart disease, stroke and metabolic disorders.
This document discusses obstructive sleep apnea (OSA). It defines OSA as recurrent episodes of apnea or hypopnea due to upper airway collapse during sleep. It reviews the prevalence of OSA in different populations and risk factors such as obesity, genetics, and upper airway abnormalities. The pathogenesis of OSA involves reduced airway size and increased collapsibility, as well as neural, muscle and fluid shift factors. Clinical symptoms, diagnostic tools like polysomnography, and treatment options including positive airway pressure and oral appliances are described in detail.
This document discusses ventilation strategies for a patient with acute respiratory distress syndrome (ARDS). It provides details of the patient's initial presentation and management, including mechanical ventilation settings. It describes the rationale for using low tidal volume ventilation to minimize ventilator-induced lung injury. The patient required aggressive management for sepsis and hypoxemia including recruitment maneuvers and increasing PEEP and mean airway pressures. Despite these efforts, the patient could not be weaned from high FiO2 and developed multi-organ failure and died. The document recommends using low tidal volumes, limiting end-inspiratory pressures, adequate PEEP, and considering recruitment maneuvers to optimize ventilation in ARDS.
The document summarizes the new sleep scoring guidelines from the American Academy of Sleep Medicine (AASM). Key changes include the addition of frontal EEG leads, closer EOG electrode placement, more chin EMG electrodes, and new definitions for sleep stages, arousals, respiratory events, and movements. The AASM guidelines were developed through an evidence-based process and aim to standardize sleep scoring based on advances in neurobiology and technology.
Sleep progresses through stages including REM sleep and NREM sleep. NREM sleep includes stages 1-4, with stages 3 and 4 being slow wave or deep sleep. A normal sleep cycle lasts 90-110 minutes and progresses from light to deep sleep and then to REM sleep before repeating. Lack of sleep or fragmented sleep can negatively impact health by reducing time in restorative sleep stages and increasing daytime sleepiness. Common sleep disorders include insomnia, sleep apnea, hypersomnias, and circadian rhythm disorders.
This document defines and describes sleep apnea, its types (obstructive, central, mixed), risk factors, symptoms, complications, diagnosis via polysomnography (PSG), and treatment options including weight loss, CPAP, oral devices, surgery, and management of obesity hypoventilation syndrome. Sleep apnea is characterized by pauses in breathing during sleep caused by airway collapse and is associated with daytime sleepiness and cardiovascular issues. PSG is the gold standard test to evaluate sleep architecture and breathing disturbances. Treatment focuses on maintaining an open airway through lifestyle changes and devices.
OSAS (OBSTRUCTIVE SLEEP APNEA SYNDROME) e disabilitàASMaD
Presentazione a cura del Professor Francescosaverio Caserta - XII° Congresso Nazionale FIMeG 2018 - The Silver Tsunami: l'anziano fra appropriatezza e farmaeconomia
This document discusses obstructive sleep apnea syndrome (OSAS). It begins by stating the prevalence of OSAS in India is 7.5% and is often undiagnosed. OSAS is characterized by cessation of airflow for more than 10 seconds during sleep that can be obstructive, central, or mixed in nature. Risk factors include obesity, older age, alcohol use, and certain medications. Polysomnography is the gold standard test used to diagnose OSAS and evaluate severity based on apnea hypopnea index. Untreated OSAS can lead to increased risks of hypertension, heart disease, stroke and metabolic disorders.
Ventilatory management of Acute Hypercapnic Respiratory FailureVitrag Shah
Presentation on ventilatory management in Acute Hypercapnic Respiratory Failure
Updated information till 17/8/16
For powerpoint format, contact dr.vitrag@gmail.com
http://www.medicalgeek.com/presentation/36513-ventilatory-management-acute-hypercapnic-respiratory-failure-presentation.html
Download review articles and guidelines for ventilatory management in COPD & Asthma
http://www.medicalgeek.com/articles-and-news/36514-articles-ventilatory-management-copd-asthma.html
Sleep Apnea – 2017 Update on Evaluation and ManagementSummit Health
The document provides an overview and update on sleep apnea, including its evaluation and treatment. It discusses the definition and types of sleep apnea, risk factors, diagnostic testing options, and treatment approaches such as CPAP, oral appliances, surgery, and lifestyle changes. The key goals in managing sleep apnea are to obtain accurate diagnostic data, educate patients, closely monitor treatment adherence, address any equipment issues, and ensure long-term follow up to optimize outcomes.
OSA is an entity that is increasingly being managed by otolaryngologists...Hope this presentation helps to clear any doubts regarding its diagnosis and management!
This document discusses obstructive sleep apnea syndrome (OSAS). It defines OSAS and describes the stages of sleep. OSAS is characterized by pauses in breathing or instances of reduced breathing during sleep. The severity is determined by the apnea-hypopnea index. Symptoms include daytime sleepiness and snoring. Risk factors include obesity, large tongue, and nasal obstruction. Treatment involves weight loss, sleep positioning, continuous positive airway pressure devices, and sometimes surgery to improve breathing during sleep. Complications of untreated OSAS include high blood pressure, heart disease, and stroke.
A very large proportion of Intensive Care Patients. Discussed in detail about causes diagnosis and management pearls of neuromuscular respiratory failure. Intensive Care Physicians will find this presentation very useful and informative.
Otoacoustic emissions are sounds produced by the inner ear and measured in the ear canal. There are four main types, including spontaneous and transiently evoked emissions produced without or in response to sound. Otoacoustic emissions are used clinically to screen hearing, estimate cochlear sensitivity, and differentiate sensory from neural hearing loss. They provide an objective, noninvasive window into cochlear function and can detect hearing losses as mild as 30-40 dB.
1) The document discusses managing difficult pediatric airways, noting assessments that should be done and potential airway anomalies.
2) It describes various techniques that can be used to secure the airway depending on the child's condition, including inhalational induction, fiberoptic intubation, LMAs, and surgical airways if needed.
3) It emphasizes the importance of avoiding neuromuscular blockade in children with uncertain or difficult airways so spontaneous ventilation and regrouping are possible if needed. Maintaining the airway takes priority over other considerations like a full stomach.
Polysomnography (PSG) is the gold standard test for diagnosing sleep disorders like obstructive sleep apnea. It involves simultaneous monitoring of multiple physiologic parameters related to sleep, including brain waves, eye movements, muscle activity, heart rate, respiration, and oxygen levels. PSG is used to diagnose sleep disorders, determine appropriate treatments like CPAP, and assess treatment effectiveness. It provides valuable information about sleep architecture and respiratory events that can help characterize a patient's condition.
This document provides an overview of mechanical ventilation, including:
1) How mechanical ventilation helps reduce the work of breathing and restore gas exchange through invasive and noninvasive positive pressure ventilation.
2) The basics of monitoring pressure, volume, flow, and pressure-time curves at the bedside.
3) Important considerations for mechanical ventilation including potential adverse effects on hemodynamics, lungs, and gas exchange, and how to address issues like auto-PEEP.
Sleep disordered breathing encompasses a spectrum of breathing abnormalities during sleep ranging from primary snoring to obstructive sleep apnea. The main types are upper airway resistance syndrome, obstructive sleep apnea, and central sleep apnea. Risk factors include obesity, large neck circumference, and family history. Consequences of untreated sleep apnea include hypertension, diabetes, heart disease, and motor vehicle accidents due to daytime sleepiness. Diagnosis involves an overnight sleep study and treatment options include weight loss, continuous positive airway pressure, oral appliances, surgery, and in rare cases pharmacotherapy.
Polysomnogram interpretation by dr md abdullah saleemsaleem051
This document provides definitions and explanations of key terms and metrics used in interpreting polysomnography tests. It describes signs and symptoms that indicate the need for a polysomnogram and defines measurements of sleep periods, stages, efficiency, and latency. It also defines the various types of respiratory events that can be observed, such as apneas, hypopneas, and arousals, and how they are calculated and classified. Finally, it outlines the process for reviewing sleep study results and making a diagnosis.
The document discusses several newer modes of mechanical ventilation including volume assured pressure support (VAPS), volume support (VS), pressure regulated volume control (PRVC), and adaptive support ventilation (ASV). VAPS switches between pressure control and volume control modes within a breath to ensure a minimum tidal volume. VS adjusts pressure support levels between breaths to maintain a target tidal volume. PRVC aims to deliver a set tidal volume with the lowest possible airway pressure by modifying flow and time. ASV automatically adapts support levels to provide a minimum minute ventilation with the least work of breathing.
This document discusses snoring and obstructive sleep apnea (OSA). It notes that OSA is a clinical condition where the upper airway collapses intermittently during sleep. Risk factors include obesity, age, hypertension, and diabetes. Untreated OSA can lead to increased risks of hypertension, heart attack, stroke, and premature death. Diagnosis involves questionnaires, physical examination, and sleep studies. Treatment aims to reduce symptoms and health risks.
This document discusses lung volumes and capacities as measured by pulmonary function tests (PFTs). It describes the key volumes and capacities including tidal volume, inspiratory reserve volume, expiratory reserve volume, residual volume, vital capacity, total lung capacity, and functional residual capacity. It provides the normal ranges for these measurements and explains their clinical significance in assessing lung function and the presence of obstructive or restrictive lung diseases. Spirometry is highlighted as the cornerstone PFT for measuring volumes like forced vital capacity (FVC) and flows like forced expiratory volume in 1 second (FEV1).
This document provides information on obstructive sleep apnea (OSA), including its physiology, risk factors, symptoms, diagnosis, and treatment. OSA involves pauses in breathing during sleep due to upper airway collapse. It is diagnosed through an overnight sleep study that measures breathing, oxygen levels, and brain waves. A high number of breathing pauses or dips in oxygen (apnea-hypopnea index over 5) indicates OSA. Common symptoms include loud snoring, witnessed breathing pauses, and daytime sleepiness. Risk factors include obesity, large neck size, and family history. Treatment typically involves a CPAP machine to keep the airway open during sleep.
1) The document discusses guidelines developed by Dr. Papadakos for sedation of critically ill patients, including the first use guidelines for propofol in neurosurgery patients and development of protocols for sedation in critically ill patients.
2) It describes goals of sedation in the ICU as well as characteristics of an ideal sedation agent. Common sedative drugs used in the ICU like benzodiazepines, propofol, and dexmedetomidine are discussed along with their mechanisms of action, pharmacodynamics, clinical effects, and limitations.
3) Sedation scales used to assess level of sedation like the Ramsay and SAS scales are also summarized.
Snoring and obstructive sleep apnea occur when the muscles in the back of the throat relax during sleep, causing vibration that produces snoring sounds or complete or partial airway obstruction. Obstructive sleep apnea is defined by cessation of breathing lasting 10 seconds or more during sleep and is classified based on the respiratory disturbance index. Polysomnography is the gold standard test used to diagnose sleep apnea and involves monitoring various physiological parameters during sleep. Treatment options include lifestyle changes, oral appliances, continuous positive airway pressure therapy, and various surgical procedures to reduce tissue volumes or advance structures in the throat.
This document provides information on Acute Respiratory Distress Syndrome (ARDS), including its history, definitions, pathophysiology, management, and related concepts like ventilator-induced lung injury. Some key points:
- ARDS was first described in 1967 and its definition has evolved, with the most widely used being the Berlin Definition from 2012.
- It is characterized by diffuse pulmonary edema and inflammation due to direct lung injury or indirect causes like sepsis.
- Management focuses on treating the underlying cause, protective lung ventilation with low tidal volumes, permissive hypercapnia, prone positioning, and recruitment maneuvers.
- Adjunctive techniques aim to prevent ventilator-induced lung injury from
Ventilatory management of Acute Hypercapnic Respiratory FailureVitrag Shah
Presentation on ventilatory management in Acute Hypercapnic Respiratory Failure
Updated information till 17/8/16
For powerpoint format, contact dr.vitrag@gmail.com
http://www.medicalgeek.com/presentation/36513-ventilatory-management-acute-hypercapnic-respiratory-failure-presentation.html
Download review articles and guidelines for ventilatory management in COPD & Asthma
http://www.medicalgeek.com/articles-and-news/36514-articles-ventilatory-management-copd-asthma.html
Sleep Apnea – 2017 Update on Evaluation and ManagementSummit Health
The document provides an overview and update on sleep apnea, including its evaluation and treatment. It discusses the definition and types of sleep apnea, risk factors, diagnostic testing options, and treatment approaches such as CPAP, oral appliances, surgery, and lifestyle changes. The key goals in managing sleep apnea are to obtain accurate diagnostic data, educate patients, closely monitor treatment adherence, address any equipment issues, and ensure long-term follow up to optimize outcomes.
OSA is an entity that is increasingly being managed by otolaryngologists...Hope this presentation helps to clear any doubts regarding its diagnosis and management!
This document discusses obstructive sleep apnea syndrome (OSAS). It defines OSAS and describes the stages of sleep. OSAS is characterized by pauses in breathing or instances of reduced breathing during sleep. The severity is determined by the apnea-hypopnea index. Symptoms include daytime sleepiness and snoring. Risk factors include obesity, large tongue, and nasal obstruction. Treatment involves weight loss, sleep positioning, continuous positive airway pressure devices, and sometimes surgery to improve breathing during sleep. Complications of untreated OSAS include high blood pressure, heart disease, and stroke.
A very large proportion of Intensive Care Patients. Discussed in detail about causes diagnosis and management pearls of neuromuscular respiratory failure. Intensive Care Physicians will find this presentation very useful and informative.
Otoacoustic emissions are sounds produced by the inner ear and measured in the ear canal. There are four main types, including spontaneous and transiently evoked emissions produced without or in response to sound. Otoacoustic emissions are used clinically to screen hearing, estimate cochlear sensitivity, and differentiate sensory from neural hearing loss. They provide an objective, noninvasive window into cochlear function and can detect hearing losses as mild as 30-40 dB.
1) The document discusses managing difficult pediatric airways, noting assessments that should be done and potential airway anomalies.
2) It describes various techniques that can be used to secure the airway depending on the child's condition, including inhalational induction, fiberoptic intubation, LMAs, and surgical airways if needed.
3) It emphasizes the importance of avoiding neuromuscular blockade in children with uncertain or difficult airways so spontaneous ventilation and regrouping are possible if needed. Maintaining the airway takes priority over other considerations like a full stomach.
Polysomnography (PSG) is the gold standard test for diagnosing sleep disorders like obstructive sleep apnea. It involves simultaneous monitoring of multiple physiologic parameters related to sleep, including brain waves, eye movements, muscle activity, heart rate, respiration, and oxygen levels. PSG is used to diagnose sleep disorders, determine appropriate treatments like CPAP, and assess treatment effectiveness. It provides valuable information about sleep architecture and respiratory events that can help characterize a patient's condition.
This document provides an overview of mechanical ventilation, including:
1) How mechanical ventilation helps reduce the work of breathing and restore gas exchange through invasive and noninvasive positive pressure ventilation.
2) The basics of monitoring pressure, volume, flow, and pressure-time curves at the bedside.
3) Important considerations for mechanical ventilation including potential adverse effects on hemodynamics, lungs, and gas exchange, and how to address issues like auto-PEEP.
Sleep disordered breathing encompasses a spectrum of breathing abnormalities during sleep ranging from primary snoring to obstructive sleep apnea. The main types are upper airway resistance syndrome, obstructive sleep apnea, and central sleep apnea. Risk factors include obesity, large neck circumference, and family history. Consequences of untreated sleep apnea include hypertension, diabetes, heart disease, and motor vehicle accidents due to daytime sleepiness. Diagnosis involves an overnight sleep study and treatment options include weight loss, continuous positive airway pressure, oral appliances, surgery, and in rare cases pharmacotherapy.
Polysomnogram interpretation by dr md abdullah saleemsaleem051
This document provides definitions and explanations of key terms and metrics used in interpreting polysomnography tests. It describes signs and symptoms that indicate the need for a polysomnogram and defines measurements of sleep periods, stages, efficiency, and latency. It also defines the various types of respiratory events that can be observed, such as apneas, hypopneas, and arousals, and how they are calculated and classified. Finally, it outlines the process for reviewing sleep study results and making a diagnosis.
The document discusses several newer modes of mechanical ventilation including volume assured pressure support (VAPS), volume support (VS), pressure regulated volume control (PRVC), and adaptive support ventilation (ASV). VAPS switches between pressure control and volume control modes within a breath to ensure a minimum tidal volume. VS adjusts pressure support levels between breaths to maintain a target tidal volume. PRVC aims to deliver a set tidal volume with the lowest possible airway pressure by modifying flow and time. ASV automatically adapts support levels to provide a minimum minute ventilation with the least work of breathing.
This document discusses snoring and obstructive sleep apnea (OSA). It notes that OSA is a clinical condition where the upper airway collapses intermittently during sleep. Risk factors include obesity, age, hypertension, and diabetes. Untreated OSA can lead to increased risks of hypertension, heart attack, stroke, and premature death. Diagnosis involves questionnaires, physical examination, and sleep studies. Treatment aims to reduce symptoms and health risks.
This document discusses lung volumes and capacities as measured by pulmonary function tests (PFTs). It describes the key volumes and capacities including tidal volume, inspiratory reserve volume, expiratory reserve volume, residual volume, vital capacity, total lung capacity, and functional residual capacity. It provides the normal ranges for these measurements and explains their clinical significance in assessing lung function and the presence of obstructive or restrictive lung diseases. Spirometry is highlighted as the cornerstone PFT for measuring volumes like forced vital capacity (FVC) and flows like forced expiratory volume in 1 second (FEV1).
This document provides information on obstructive sleep apnea (OSA), including its physiology, risk factors, symptoms, diagnosis, and treatment. OSA involves pauses in breathing during sleep due to upper airway collapse. It is diagnosed through an overnight sleep study that measures breathing, oxygen levels, and brain waves. A high number of breathing pauses or dips in oxygen (apnea-hypopnea index over 5) indicates OSA. Common symptoms include loud snoring, witnessed breathing pauses, and daytime sleepiness. Risk factors include obesity, large neck size, and family history. Treatment typically involves a CPAP machine to keep the airway open during sleep.
1) The document discusses guidelines developed by Dr. Papadakos for sedation of critically ill patients, including the first use guidelines for propofol in neurosurgery patients and development of protocols for sedation in critically ill patients.
2) It describes goals of sedation in the ICU as well as characteristics of an ideal sedation agent. Common sedative drugs used in the ICU like benzodiazepines, propofol, and dexmedetomidine are discussed along with their mechanisms of action, pharmacodynamics, clinical effects, and limitations.
3) Sedation scales used to assess level of sedation like the Ramsay and SAS scales are also summarized.
Snoring and obstructive sleep apnea occur when the muscles in the back of the throat relax during sleep, causing vibration that produces snoring sounds or complete or partial airway obstruction. Obstructive sleep apnea is defined by cessation of breathing lasting 10 seconds or more during sleep and is classified based on the respiratory disturbance index. Polysomnography is the gold standard test used to diagnose sleep apnea and involves monitoring various physiological parameters during sleep. Treatment options include lifestyle changes, oral appliances, continuous positive airway pressure therapy, and various surgical procedures to reduce tissue volumes or advance structures in the throat.
This document provides information on Acute Respiratory Distress Syndrome (ARDS), including its history, definitions, pathophysiology, management, and related concepts like ventilator-induced lung injury. Some key points:
- ARDS was first described in 1967 and its definition has evolved, with the most widely used being the Berlin Definition from 2012.
- It is characterized by diffuse pulmonary edema and inflammation due to direct lung injury or indirect causes like sepsis.
- Management focuses on treating the underlying cause, protective lung ventilation with low tidal volumes, permissive hypercapnia, prone positioning, and recruitment maneuvers.
- Adjunctive techniques aim to prevent ventilator-induced lung injury from
Speech su IERING al Convegno di Barcellona 2007Salvo Reina
1. SOFTWARE DEDICATO ALLA PATOLOGIA ENDOMETRIOSICA 83° Congresso Nazionale SIGO 48° Congresso Nazionale AOGOI - 15° Congresso Nazionale AGUI Napoli - 14-17 Ottobre 2007 - Mostra d'Oltremare Dr. Alessandro FASCIANI E.O. Ospedali Galliera di Genova Ospedale di rilievo nazionale e di alta (D.P.C.M. 14 luglio 1995) Struttura Complessa di Ostetricia e Ginecologia Direttore Dr. Felice Repetti
2. • Le stime di prevalenza configurano l'endometriosi come una priorità nell'ambito dei programmi di tutela della salute pubblica. • La carenza di informazione diffusa, l'assenza di protocolli terapeutici univoci e condivisi e la attuale scarsa disponibilità di servizi territoriali adeguati sono fattori che creano forte aspettativa e rendono complessa la definizione e l'attuazione di programmi efficaci di prevenzione, di diagnosi precoce e di cura. • I recenti dati internazionali indicano un ritardo diagnostico di circa dieci anni nonché frequenti diagnosi sbagliate dovute alla mancanza di consapevolezza e comprensione dei sintomi.
3. NECESSITA’ DI UNO STRUMENTO CHE CONSENTA
4. • Una delle possibili soluzioni a questo problema è quello di standardizzare, computare e analizzare in maniera obiettiva e riproducibile tutti i dati generati dal percorso diagnostico-terapeutico con approccio multidisciplinare che le pazienti affrontano quando vi sia endometriosi. • Ogni giorno una grandissima quantità di informazioni è presente ai tempi della valutazione pre-chirurgica, dell’osservazione della pelvi in sala operatoria e a tutti i controlli successivi cui si sottopongono le Donne con endometriosi.
5. OBIETTIVI 1. Archiviare le informazioni cliniche raccolte durante il percorso diagnosticoterapeutico per endometriosi, 2. Elaborarle in modo da condurre ad un parametro numerico che rifletta e quantifichi lo stato di patologia al tempo di ogni visita medica, 3. Generare un test non invasivo, predittivo di endometriosi e capace di ridurre il ritardo di diagnosi e predire la sua recidiva.
6. SOFTWARE DEDICATO ALLA PATOLOGIA ENDOMETRIOSICA Dati Paziente
7. SOFTWARE DEDICATO ALLA PATOLOGIA ENDOMETRIOSICA Valutazione Medica
8. SOFTWARE DEDICATO ALLA PATOLOGIA ENDOMETRIOSICA Informazioni salvate ed elaborate in un valore di patologia endometriosica
9. 72 pazienti inviate al nostro ambulatorio per sospetta endometriosi, dolore pelvico e infertilità hanno eseguito il percorso diagnostico terapeutico software-assistito dal Maggio 2005 al Luglio 2007 Tutte le Pazienti sono state operate con videoregistrazione su rete informatica dell’Ospedale 11 no aderenze pelviche Assenza di Endometriosi = controlli 57 Endometriosi – Stadiazione rev-AFS – Conferma istologica 4 con aderenze pelviche Assenza di Endometriosi Controllo post-chirurgico + follow-up software assistito
10. L’IE calcolato prima della chirurgia in pazienti risultate essere affette da endometriosi è risultato significativamente più elevato (p<0.0001) di quello generato da donne senza endometriosi/aderenze. ....
Integrazione precoce delle Cure Palliative in OncoematologiaWega Formazione
Integrazione precoce delle Cure Palliative in Oncoematologia - Claudio Cartoni - Unità Cure Palliative e Domiciliari - UOC Ematologia Policlinico Umberto I, Roma
Health ICT in European and Italian primary careSabina De Rosis
"Information Technology nelle cure primarie"
presentazione orale tenuta da Sabina De Rosis
Convegno nazionale organizzato dal Laboratiorio Management e Sanità della Scuola Superiore Sant'Anna di Pisa (SSSUP) con la collaborazione di Wonca Italia
"QUALICOPC: Quality and Costs of Primary Care
Risultati ed esperienze internazionali e nazionali a confronto"
12 maggio 2014
Scuola Superiore Sant'Anna
Aula Magna
Ore 9.00 - 17.00
http://www.nivel.nl/en/qualicopc/
ASPETTI EMATOLOGICI DELLA MALATTIA DI GAUCHER: DALLA DIAGNOSI AL TRATTAMENTOCentroMalattieRareFVG
Slides presentate dai relatori durante il corso avanzato "Aspetti ematologici della malattia di Gaucher: dalla diagnosi al trattamento", che si è tenuto a Udine nei giorni 25 e 26 ottobre 2017.
Slides presentate dai relatori durante il corso avanzato "Aspetti ematologici della malattia di Gaucher: dalla diagnosi al trattamento", che si è tenuto a Udine nei giorni 25 e 26 ottobre 2017.
Corso avanzato ASPETTI EMATOLOGICI DELLA MALATTIA DI GAUCHER: DALLA DIAGNOSI ...CentroMalattieRareFVG
Slides presentate dai relatori durante il corso avanzato "Aspetti ematologici della malattia di Gaucher: dalla diagnosi al trattamento", che si è tenuto a Udine nei giorni 25 e 26 ottobre 2017.
Slides presentate dai relatori durante il corso avanzato "Aspetti ematologici della malattia di Gaucher: dalla diagnosi al trattamento", che si è tenuto a Udine nei giorni 25 e 26 ottobre 2017.
Slides presentate dai relatori durante il corso avanzato "Aspetti ematologici della malattia di Gaucher: dalla diagnosi al trattamento", che si è tenuto a Udine nei giorni 25 e 26 ottobre 2017.
Presentazione realizzata dal dr Lorenzo Verriello, coordinatore della Rete Regionale delle Malattie Neuromuscolari e della SLA, per illustrare il funzionamento e gli obiettivi della stessa.
Il Riordino della Rete Regionale delle Malattie Rare in Friuli Venezia GiuliaCentroMalattieRareFVG
Nel corso del 2017 è stata ristrutturata la rete regionale delle Malattie Rare del Fiuli Venezia Giulia. In questa presentazione, realizzata dal dr Bruno Bembi, Direttore del Centro di Coordinamento Regionale per le Malattie Rare, sono illustrati il percorso che ha portato al riordino della rete, la filosofia che lo ha ispirato e il funzionamento della rete stessa.
Storia clinica della Malattia di Gaucher tipo 1 dopo l'introduzione della Ter...CentroMalattieRareFVG
Slides presentate dal dr Bruno Bembi, Direttore del Centro di Coordinamento Regionale per le Malattie Rare FVG e Principal Investigator del progetto di Ricerca Finalizzata "Clinical history and long-term cost-effectiveness of Enzyme Replacement Therapy for Gaucher Disease in Italy", in occasione del convegno "Patologia Immune e Malattie Orfane", Torino, 28-30 gennaio 2016.
Presentazione realizzata dalla dr.ssa Daniela Miani, cardiologa presso l'AOU S. Maria della Misericordia di Udine" per il corso "La Malattia di Fabry: conoscere per riconoscere", Udine, 17 giugno 2015.
Slides presentate dalla dr.ssa Andrea Dardis, responsabile del Laboratorio del Centro Malattie Rare di Udine, al corso "La malattia di Fabry: conoscere per riconoscere", Udine, 17 giugno 2015.
Inquadratura soggettiva: Affettività e Sessualità attraverso Lo sguardo dei P...CentroMalattieRareFVG
Affettività e sessualità nella disabilità: una sfida per gli operatori
Inquadratura soggettiva:
Affettività e Sessualità attraverso
Lo sguardo dei Protagonisti
Dott. Daniele Ferraresso
Esperto nei processi formativi orientati all’autonomia
Pedagogista Clinico
Udine, 15 Aprile 2015
L’esperienza affettiva-sessuale della persona con disabilità intellettiva in ...CentroMalattieRareFVG
Affettività e sessualità nella disabilità: una sfida per gli operatori
L’esperienza affettiva-sessuale della persona con disabilità intellettiva in un’ottica psico-relazionale
Dott.ssa Orietta Sponchiado
Psicologa-psicoterapeuta
Udine, 15 aprile 2015
Affettività e rischio psicopatologico delle disabilità intellettiveCentroMalattieRareFVG
AFFETTIVITÀ E
RISCHIO
PSICOPATOLOGICO
DELLE DISABILITÀ
INTELLETTIVE
Daniele Fedeli
Professore Associato di
Pedagogia Speciale
Università degli Studi di Udine
Affettività e rischio psicopatologico delle disabilità intellettive
L'interessamento respiratorio nelle malattie neuromuscolari e la gestione trapeutica
1. Le malattie neuromuscolari dell’adulto: dalla diagnosi al follow-up e gestione delle
complicanze. Creazione di un precorso assistenziale coordinato per le malattie neuromuscolari
AUOD – 16 dicembre 2013
L’interessamento respiratorio
nelle malattie neuromuscolari
e la gestione terapeutica
Vincenzo Patruno
SOC Pneumologia Riabilitativa
ASS4 Mediofriuli
IMFR – Gervasutta -UD
4. RIDUZIONE DELLA FORZA DEI MUSCOLI RESPIRATORI
Riduzione della pompa ventilatoria
Alterazione dello scambio dei gas
RIDUZIONE DELLA EFFICACIA DELLA TOSSE
Riduzione “clearance” delle secrezioni endobronchiali
aumento delle infezioni respiratorie
RIDUZIONE DELLA “CONTINENZA” DELLA GLOTTIDE
Fenomeni di inalazione ricorrenti
lesioni addensative parenchimali
LE COMPLICANZE RESPIRATORIE DELLE NMD
5. RIDUZIONE DELLA POMPA VENTILATORIA ipossia/ipercapnia
riduzione di Capacità Vitale
ridotta forza muscolare respiratoria
ridotta forza diaframma
valutazione scambio dei gas in veglia (EGA o SpO2 / TC-CO2)
valutazione scambio dei gas notturno (Saturimetria notturna)
LE COMPLICANZE RESPIRATORIE DELLE NMD
6. RIDUZIONE DELLA EFFICACIA DELLA TOSSE
compromissione dei muscoli inspiratori/espiratori
compromissione diaframmatica
compromissione della continenza della glottide
valutazione efficacia tosse (PCF) Picco Flusso Sotto Tosse
LE COMPLICANZE RESPIRATORIE DELLE NMD
7. RIDUZIONE DELLA “CONTINENZA” DELLA GLOTTIDE
LE COMPLICANZE RESPIRATORIE DELLE NMD
compromissione BULBARE
valutazione della competenza bulbare
valutazione della continenza glottide
8. 1. anticipano le complicazioni respiratorie più gravi
2. prospettano inefficacia delle “countermeasures
ALTERAZIONI COMPETENZA BULBARE
9. 1) Sintomi di ipoventilazione notturna
anticipano le alterazioni diurne dello scambio dei gas
ALTERAZIONI SONNO-CORRELATE
10. 2) Le valutazioni strumentali notturne
rilevano DRS non sempre clinicamente evidenti
ALTERAZIONI SONNO-CORRELATE
12. RIDUZIONE DELLA POMPA VENTILATORIA
ventilazione meccanica non invasiva
RIDUZIONE DELLA EFFICACIA DELLA TOSSE
tecniche di air-staking
in-exsufflator
COMPROMISSIONE DELLA CONTINENZA DELLA GLOTTIDE
PEG
ventilazione meccanica invasiva
minitrach
Opzioni terapeutiche
nelle complicanze respiratorie
13. RIDUZIONE DELLA POMPA VENTILATORIA
ventilazione meccanica non invasiva
Opzioni terapeutiche
nelle complicanze respiratorie
14. INDICAZIONE ALL’AVVIAMENTO ALLA NIV DOMICILIARE
1) Sintomi di ipoventilazione notturna
2) Dato EGA di ipossia – Ipercapnia
3) Dato S.N. di desaturazioni notturne
15. Long term Niv use is associated with an
increase in survival in DMD patients
Total Duchenne muscular
dystrophy population in
Denmark 1977-2001
Mortality 4.7 2.6 / 100 years
NIV users 0.9 43.4 per 100
Jeppesen et al. Neuromuscular Disorders 2003;13:804
16. AVVIAMENTO ALLA NIV DOMICILIARE
1) Presuppone ADDESTRAMENTO
2) Necessita di TITOLAZIONE
3) Impone CONTROLLI DI FOLLOW-UP
17. RIDUZIONE DELLA EFFICACIA DELLA TOSSE
air-staking
in-exsufflator
Opzioni terapeutiche
nelle complicanze respiratorie
predisponendo ad episodi imprevisti di ingombro tracheo-bronchiale. L’utilizzo di b
e teofillinici non ha alcun effetto su episodi di ingombro tracheo-bronchiale dovuti al
della tosse.
Alcuni autori propongono l’utilizzo di steroidi per via aerosolica allo scopo
l’ipersecrezione secondaria alla flogosi delle vie aeree. E’ fondamentale il mantenim
corretta idratazione.
19. COMPROMISSIONE DELLA CONTINENZA DELLA GLOTTIDE
PEG
ventilazione meccanica invasiva
minitrach
Opzioni terapeutiche
nelle complicanze respiratorie
20. In caso di compromissione bulbare severa con marcata
incontinenza della glottide
NIV e assistenza tosse sono inefficaci
Considerare allora la tracheotomia
per permettere la ventilazione invasiva
Oppure la minitracheotomia
per permettere aspirazioni endobronchiali
Opzioni terapeutiche
nelle complicanze respiratorie
21. presa in carico pneumologica
• Quando e se......
– Quando PEG ?
– Quando (se) NIv ?
– Quando In-ex ?
– Quando Air-staking ?
– Quando (se) VM ?
• Chi lo fa e come....
– Chi controlla/cambia PEG ?
– Chi controlla/cambia la CT ?
– Chi controlla NIv/VM ?
– Chi chiamare quando….. ?
21
22. Presa in carico pneumologica
• AMBULATORIO DEDICATO
–Inquadramento iniziale
–Gestione del follow-up
• programma sorveglianza a domicilio
–Personale formato
–Strategia sostenibile
–Alleati sul territorio
• Accesso dedicato per l’acuzie (UTIR)
22
23. 1) valenza diagnostico-funzionale
•individuare precoci indici funzionali prognostici per la debolezza muscolare e IRC,
•individuare il livello e la velocità di peggioramento di tali indici funzionali
2) valenza terapeutica specifica
•instaurare dove necessario una precoce terapia (riabilitativa, ventilatoria)
•valutare il livello di multidisciplinarietà necessaria ad affrontare la situazione
3) valenza di supporto educazionale
•valutare la disabilità motoria e il coinvolgimento psicologico del paziente
•valutare il coinvolgimento psicologico del care-giver
23
Ambulatorio dedicato: cosa deve saper fare
24. Condurre accuratamente i test funzionali
• Valutazione scambio dei gas in veglia:
–EGA in aria ambiente
–SaO2 in aria ambiente + TC-CO2
• Valutazione scambio dei gas durante sonno
–Saturimetria notturna
–MCR
• Valutazione funzionalità respiratoria:
–Esame spirometrico
• Valutazione efficacia della tosse:
–Picco di flusso sotto tosse
–Picco di flusso sotto tosse assistita (spinte addominali)
–Picco di flusso sotto tosse assistita post-insufflazione forzata (AMBU+spinte addominali)
• Valutazione competenza bulbare:
–Scala Bulbare di Norris
• Valutazione continenza glottide
–PCF/PEF:
–MIC/CV:
• Valutazione forza muscolare respiratoria in toto:
–MIP -- MEP
• Valutazione funzionale diaframma:
• pletismografia toraco-addominale
• CV sdraiata / CV seduta
• SNIP cmH2O
24
Ambulatorio dedicato: cosa deve saper fare
25. Calibrare il timing del follow-up
•sulla patologia di base
(evolutiva, rapidamente evolutiva, lentamente evolutiva)
•sul tipo di compromissione attesa
Ambulatorio dedicato: cosa deve saper fare
26. Offrire tutte le necessarie opzioni terapeutiche
• tecniche di assistenza manuale alla tosse (air-stacking)
• tecniche di assistenza meccanica alla tosse (M-IE)
• Indicazione/Programmazione PEG
• Indicazione/Programmazione tracheotomia elettiva
• avviamento/addestramento ventilazione meccanica
invasiva/non invasiva
• necessità di materiale per la VM, necessità di ri-settaggio del ventilatore, controllo delle
interfacce di ventilazione e dei materiali di consumo, pazienti con problemi burocratici da
risolvere
26
Ambulatorio dedicato: cosa deve saper fare
27. Sviluppare percorsi educazionali e di supporto
“Counseling/consulting” sulle problematiche
respiratorie in essere/future
per i care-givers,
per gli operatori sul territorio (ADI),
per i MMG
•Consulting Bioetico per gli operatori
27
Ambulatorio dedicato: cosa deve saper fare
28. AMBULATORIO DEDICATO : cosa dovrà riuscire a fare...
tutto questo ma non in ospedale!!!
+
programma di sorveglianza domiciliare (telemedicina)
28
29. A che punto siamo in ASS4?
• Abbiamo un nodo di accesso consolidato (Neurologia AOUD)
• Abbiamo un ambulatorio pneumologico dedicato (PNL Gervasutta)
• Abbiamo una struttura ospedaliera di sostegno per procedure chirurgiche come
PEG e tracheo (H. San Daniele)
• Abbiamo una struttura ospedaliera per la gestione in condizioni di stabilità
(Gervasutta)
• Abbiamo una struttura ospedaliera di sostegno palliativo (Hospice di
Martignacco e Hospice di San Vito al Tagliamento)
E’ in fase attuativa un sistema di sorveglianza a domicilio con un progetto pilota
finanziato (UILDM)
E’ in fase di definizione il sistema di rete per la gestione della acuzie
29